Abul-Hajj Y J, Iverson R, Kiang D T
Steroids. 1979 Dec;34(7):817-27. doi: 10.1016/0039-128x(79)90094-1.
The metabolism of 7-(3)H-pregnenolone was studied in vitro using 16 human breast carcinomas. All mammary tumors transformed pregnenolone to progesterone. All estrogen receptor poor tumors and 4 out of 8 estrogen receptor rich tumors converted pregnenolone to 17-hydroxypregnenolone. Five estrogen receptor poor tumors showed the presence of 17,20-lyase as evidenced by formation of dehydroepiandrosterone and androstenedione. In two estrogen receptor poor tumors, conversions of pregnenolone to progesterone, 17-hydroxy pregnenolone, dehydroepiandrosterone, androstenedione and finally to estradiol was documented, providing a hypothetical pathway for steroid metabolism in human breast cancer. The conversion of pregnenolone to 17-hydroxypregnenolone was significantly less in receptor rich tumors and was totally absent in 4 receptor rich tumors with estrogen receptors of over 45 fmol/mg protein.
使用16例人乳腺癌在体外研究了7-(3)H-孕烯醇酮的代谢。所有乳腺肿瘤都将孕烯醇酮转化为孕酮。所有雌激素受体阴性肿瘤以及8例雌激素受体阳性肿瘤中的4例将孕烯醇酮转化为17-羟孕烯醇酮。5例雌激素受体阴性肿瘤显示存在17,20-裂解酶,这可通过脱氢表雄酮和雄烯二酮的形成得到证明。在2例雌激素受体阴性肿瘤中,记录到了孕烯醇酮向孕酮、17-羟孕烯醇酮、脱氢表雄酮、雄烯二酮以及最终向雌二醇的转化,为人类乳腺癌中的类固醇代谢提供了一条假设途径。在雌激素受体阳性肿瘤中,孕烯醇酮向17-羟孕烯醇酮的转化明显较少,在4例雌激素受体超过45 fmol/mg蛋白的雌激素受体阳性肿瘤中完全不存在这种转化。